PT1478329E - Composicao administravel por via oral para fotoproteccao da pele - Google Patents

Composicao administravel por via oral para fotoproteccao da pele

Info

Publication number
PT1478329E
PT1478329E PT03742550T PT03742550T PT1478329E PT 1478329 E PT1478329 E PT 1478329E PT 03742550 T PT03742550 T PT 03742550T PT 03742550 T PT03742550 T PT 03742550T PT 1478329 E PT1478329 E PT 1478329E
Authority
PT
Portugal
Prior art keywords
photoprotection
skin
administrable composition
oral administrable
oral
Prior art date
Application number
PT03742550T
Other languages
English (en)
Inventor
Lionel Breton
Bureau-Franz Isabelle
Fanchon Chantal
Original Assignee
Nestle Sa
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa, Oreal filed Critical Nestle Sa
Publication of PT1478329E publication Critical patent/PT1478329E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT03742550T 2002-02-21 2003-02-18 Composicao administravel por via oral para fotoproteccao da pele PT1478329E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075703 2002-02-21

Publications (1)

Publication Number Publication Date
PT1478329E true PT1478329E (pt) 2006-09-29

Family

ID=27741186

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03742550T PT1478329E (pt) 2002-02-21 2003-02-18 Composicao administravel por via oral para fotoproteccao da pele

Country Status (23)

Country Link
US (2) US20050069505A1 (pt)
EP (1) EP1478329B1 (pt)
JP (1) JP2005526038A (pt)
KR (1) KR20040096604A (pt)
CN (1) CN1301708C (pt)
AR (1) AR038594A1 (pt)
AT (1) ATE325604T1 (pt)
AU (1) AU2003232184B2 (pt)
BR (1) BR0307875B1 (pt)
CA (1) CA2477144C (pt)
DE (1) DE60305159T2 (pt)
DK (1) DK1478329T3 (pt)
ES (1) ES2263990T3 (pt)
HK (1) HK1079104A1 (pt)
MX (1) MXPA04008177A (pt)
NO (1) NO20043848L (pt)
PL (1) PL372146A1 (pt)
PT (1) PT1478329E (pt)
RU (1) RU2309760C2 (pt)
TW (1) TWI344845B (pt)
UA (1) UA77066C2 (pt)
WO (1) WO2003070203A1 (pt)
ZA (1) ZA200407551B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106131A1 (en) * 2002-02-21 2005-05-19 Lionel Breton Photoprotective orally administrable composition for skin
DE60305159T2 (de) * 2002-02-21 2007-03-15 Société des Produits Nestlé S.A. Oral verabreichbare zusammensetzung zum schutz der haut vor licht
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
BRPI0417307A2 (pt) * 2003-12-04 2008-12-30 Biofilms Strategies Inc mÉtodos e composiÇÕes para impedir as formaÇÕes de biofilme, reduzindo os biofilmes existentes, e para reduzir os biofilmes existentes, e para reduzir as populaÇÕes de bactÉria
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
MX2007004135A (es) * 2004-10-04 2007-06-15 Oreal Composicion cosmetica y/o dermatologica para pieles sensibles.
US20060269508A1 (en) 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
WO2006110631A1 (en) 2005-04-08 2006-10-19 The Procter & Gamble Company Methods of use of orally administered probiotic bifidobacteria for human beauty benefits
AT501919B1 (de) * 2005-06-14 2008-09-15 Erber Ag Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung
US20110082218A1 (en) * 2006-06-15 2011-04-07 Karin Wertz Treatment and modulation of gene expression and skin aging
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
JP5860396B2 (ja) * 2009-05-11 2016-02-16 ネステク ソシエテ アノニム ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
US20130004463A1 (en) * 2010-01-06 2013-01-03 Kabushiki Kaisha Yakult Honsha Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application
WO2012002322A1 (ja) * 2010-06-28 2012-01-05 株式会社ヤクルト本社 経口用皮膚性状改善剤
US9259019B2 (en) * 2010-11-11 2016-02-16 Mars, Incorporated Bifidobacteriumstrain
EA028377B1 (ru) 2011-04-08 2017-11-30 Кр. Хансен А/С Противомикробная композиция
MY171851A (en) 2011-06-20 2019-11-04 Heinz Co Brands H J Llc Probiotic compositions and methods
US9113653B2 (en) * 2011-08-19 2015-08-25 Steven J Maranz Methods of administering probiotic organisms that synthesize carotenoid compounds in situ to enhance human health and nutrition
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
US10059919B2 (en) 2012-04-09 2018-08-28 Chr. Hansen A/S Bioprotection using Lactobacillus paracasei strains
EA036321B1 (ru) 2012-04-09 2020-10-26 Кр. Хансен А/С Штамм lactobacillus paracasei chcc12777 dsm24651, обладающий противогрибковыми свойствами
CN113730442A (zh) 2014-10-31 2021-12-03 潘德勒姆治疗公司 与病症的微生物治疗和诊断有关的方法和组合物
US20160271189A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
KR20180056775A (ko) 2015-10-07 2018-05-29 갈데르마 리써어치 앤드 디벨로프먼트 유산균 함유 조성물 및 아토피 피부염을 치료하기 위한 이의 용도
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
US11207360B2 (en) * 2017-11-28 2021-12-28 NUTRAVIS S.r.l. Composition for the treatment of dysbiosis of the intestinal microbiota
DE102018000033A1 (de) * 2018-01-03 2019-07-25 Torsten Schott Verfahren zur beschleunigten Allgemein- und Hautregeneration sowie Wundheilung
GB202115797D0 (en) * 2021-11-03 2021-12-15 Iiaa Ltd Compositions comprising probiotic and postbiotic strains of bacteria

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US539773A (en) * 1895-05-21 Carburetor
US3920834A (en) * 1970-07-10 1975-11-18 Hoffmann La Roche Light-screening compositions and method
DE3024318A1 (de) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
US4646362A (en) * 1985-01-10 1987-03-03 Kimberly-Clark Corporation Disposable underpants, such as child's training pants and the like
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
CH680972A5 (pt) * 1990-09-28 1992-12-31 Nestle Sa
DE69219768T2 (de) * 1992-07-06 1997-08-28 Nestle Sa Milchbakterien
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
FR2698268B1 (fr) 1992-11-24 1995-01-20 Oreal Composition photoprotectrice administrée par voie orale.
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
FR2718752B1 (fr) 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
FR2725896B1 (fr) 1994-10-19 1996-11-29 Sederma Sa Nouvelles compositions cosmetiques ou dermopharmaceutiques
IT1274654B (it) 1995-02-28 1997-07-18 Newpharma Srl Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
US6030650A (en) * 1996-11-22 2000-02-29 Princeton Nutrition, L.L.C. Complete nutritional milk compositions and products
EP0931543B1 (de) 1997-12-19 2002-03-20 MERCK PATENT GmbH Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
EP1067945B1 (en) * 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
DE19819475A1 (de) * 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1020123A1 (en) * 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
JP2001000142A (ja) * 1999-06-23 2001-01-09 Artnature Co Ltd 育毛および発毛用栄養補助食品
ATE512594T1 (de) * 1999-09-09 2011-07-15 Nestle Sa Verbesserung des zustandes älterer haustiere
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
US6617356B2 (en) * 2000-01-03 2003-09-09 Naturally Scientific Inc Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements
IL151596A0 (en) * 2000-03-24 2003-04-10 Nestle Sa Use of lactic acid bacterium for the treatment of peritonitis
EP1151673A3 (en) * 2000-05-03 2002-01-02 Societe Des Produits Nestle S.A. Confectionery product having a filling
CN100553646C (zh) * 2000-10-06 2009-10-28 雀巢产品股份有限公司 用乳酸菌微生态制剂调节皮肤免疫系统
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
ES2462535T3 (es) * 2002-02-21 2014-05-23 Societe des Produits Nestlé S.A. Composición de pienso para animales de compañía destinada a proteger la piel de la radiación solar
DE60305159T2 (de) * 2002-02-21 2007-03-15 Société des Produits Nestlé S.A. Oral verabreichbare zusammensetzung zum schutz der haut vor licht
US20050106131A1 (en) * 2002-02-21 2005-05-19 Lionel Breton Photoprotective orally administrable composition for skin

Also Published As

Publication number Publication date
CA2477144C (en) 2011-06-14
AR038594A1 (es) 2005-01-19
ES2263990T3 (es) 2006-12-16
NO20043848L (no) 2004-09-14
CN1301708C (zh) 2007-02-28
BR0307875B1 (pt) 2014-12-23
TWI344845B (en) 2011-07-11
UA77066C2 (en) 2006-10-16
US20070280999A1 (en) 2007-12-06
EP1478329B1 (en) 2006-05-10
US20050069505A1 (en) 2005-03-31
DE60305159T2 (de) 2007-03-15
US10688139B2 (en) 2020-06-23
MXPA04008177A (es) 2005-06-08
RU2004127986A (ru) 2005-05-10
ZA200407551B (en) 2005-10-12
EP1478329A1 (en) 2004-11-24
HK1079104A1 (en) 2006-03-31
KR20040096604A (ko) 2004-11-16
CA2477144A1 (en) 2003-08-28
TW200307555A (en) 2003-12-16
CN1635865A (zh) 2005-07-06
RU2309760C2 (ru) 2007-11-10
PL372146A1 (en) 2005-07-11
WO2003070203A1 (en) 2003-08-28
BR0307875A (pt) 2004-12-28
JP2005526038A (ja) 2005-09-02
DK1478329T3 (da) 2006-08-28
AU2003232184B2 (en) 2008-11-13
DE60305159D1 (de) 2006-06-14
AU2003232184A1 (en) 2003-09-09
ATE325604T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
PT1478329E (pt) Composicao administravel por via oral para fotoproteccao da pele
PT1490077E (pt) Composição fotoprotectora para a pele administrável por via oral
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA04008187A (es) Composicion de alimento para mascotas, para la fotoproteccion de la piel.
BRPI0412978A (pt) cultura biologicamente pura de grupo bacteriano, co-cultura bacteriana, composição terapêutica, aditivo ou suplemento alimentar, gênero alimentìcio, método para tratar ou prevenir desordem e artigo de manufatura
MXPA05014166A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
LUC00065I2 (pt)
CA2292706A1 (en) Method for administering viable microorganism composition for poultry
EP2261236A3 (en) Composition for proteasome inhibition
SI2169050T1 (sl) Postopek za pripravo nealergijskih probiotičnih bakterijskih kultur in njihova uporaba
WO2005110445A3 (en) Methods and compositions for the dietary management of autoimmune disorders
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
BRPI0417825A (pt) métodos para uso de lactobacilli probióticos para animais de estimação
RS52651B (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR ESTROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE
WO2004091483A3 (en) Once daily formulations of tetracyclines
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
NO20043752L (no) Fremstilling av et smaksforsterkende hydrolysat fra en bakteriekultur som omfatter en metanotrof bakterie.
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
NO20062878L (no) Isoflavonoidpromedikamenter, terapeutiske sammensetninger derav og terapeutiske fremgangsmater som innbefatter de samme
AR025020A1 (es) Forma de administracion oral que contiene al menos una especie de microorganismos probioticos, y procedimiento para su preparacion
DE60317165D1 (de) Bakterielle autolysate
BR0315247A (pt) Composição, composição farmacêutica, método de tratamento para uma doença proliferativa celular, e, kit
TW200504220A (en) Formulations comprising vitamin B12, method of production and use thereof